Clinical Trials Browser

Withdrawn × Interventional × Amyloidosis × Clear all

NCT05486481 2025-03-06

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Phase 1/2 Withdrawn

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT04984330 2022-11-17

STARR

Phase EARLY_PHASE1 Withdrawn

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis